Case Report of China/Tianjin's First Novel Coronavirus Variant Omicron.
Iran J Immunol
; 19(1): 11, 2022 Mar.
Article
in English
| MEDLINE | ID: covidwho-1934861
ABSTRACT
COVID-19 is a new acute respiratory infectious disease caused by a novel Coronavirus (2019-COV-2) infection. On November 26, 2021, the World Health Organization announced a new 2019-COV-2 variant strain Omicron (B.1.1.529). Omicron's emergence added further uncertainty to the outbreak. Here we report the first case infected with Omicron in China, a 17-year-old female student. In this paper, the clinical symptoms, laboratory and imaging examinations and treatment of the first Omicron-infected patient in China were analyzed. This report might provide a reference for the diagnosis and treatment of patients infected with Omicron strain across the world. The novel Coronavirus antibody tests were performed on the day of admission IgM level was normal, novel Coronavirus antibody IgG was 132.666s /CO and IgG was 148.47s /CO on the 7th day of admission. IgG showed an increasing trend, which is consistent with the results of multiple novel Coronavirus non-Omicron strain infections.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19
Type of study:
Case report
/
Observational study
/
Prognostic study
Topics:
Variants
Limits:
Adolescent
/
Female
/
Humans
Country/Region as subject:
Asia
Language:
English
Journal:
Iran J Immunol
Year:
2022
Document Type:
Article
Affiliation country:
Iji.2022.94050.2278
Similar
MEDLINE
...
LILACS
LIS